Sandy Liebhard

Sandy A. Liebhard, a founding partner at Bernstein Liebhard LLP, has successfully represented plaintiffs in complex litigations for more than 20 years. As dedicated consumer advocates, Mr. Liebhard and his fellow attorneys have taken on some of the largest corporate interest in the nation in cases involving dangerous pharmaceuticals, faulty medical devices and defective consumer products. As an author for RXInuryHelp.com, Mr. Liebhard has written extensively on the litigation involving proton pump inhibitors (Nexium, Prilosec, PrevAcid, etc.) and kidney injuries; Risperdal and gynecomastia; the Bair Hugger forced air warming blanket; talcum powder and ovarian cancer; transvaginal mesh; power morcellators; defective hip implants; and more.

Mr. Liebhard is a 1988 graduate of Brooklyn Law School. He is admitted to the Bar of the State of New York, as well as the United States District Courts for the Southern and Eastern Districts of New York.


Levaquin, Other Fluoroquinolones Rank as Number One Choice For Uncomplicated UTIs

A new analysis has revealed that fluoroquinolone medications rank as the top choice for treating uncomplicated urinary tract infections (UTIs) in women. The authors of the study, which was published online August 2nd in Open Forum Infections Diseases, voiced concern … Continue reading

Investor Group Shorts St. Jude Stock Over Cardiac Device Hacker Fears, Urges Recall

St Jude Medical was forced to temporarily halt trading of its stock last Friday, after an investment group asserted that the company’s implantable cardiac devices were an easy target for hackers and should be recalled. While St. Jude’s shares recovered … Continue reading

Sanofi-Aventis Files Response in Support of Taxotere Lawsuit Consolidation

Sanofi-Aventis, currently named a defendant in dozens of Taxotere lawsuits over the cancer drug’s alleged propensity to cause permanent hair loss, has voiced its support for  a plan to centralize all such  federally-filed cases in a single U.S. District Court … Continue reading

Study Suggests Risperdal in Early Pregnancy Might Increase Birth Defects Risk

The findings of a new study suggest that babies born to women who take Risperdal during the early months of  pregnancy may be more likely to suffer from birth defects. However, other antipsychotic medications do not appear to be associated … Continue reading

Study Sees Decline in Uterine Morcellation Following FDA Cancer Warning

A new study suggests that doctors have sharply curtailed their use of uterine morcellation in the wake of warnings from the U.S. Food & Drug Administration (FDA). However, the decline has not resulted in an increased rate of hysterectomy complications, … Continue reading

Johnson & Johnson Promises Talcum Powder Lawsuit Appeals

Johnson & Johnson, which found itself on the losing end of two high-profile talcum powder lawsuits earlier this year, has promised to appeal the massive verdicts rendered in those cases. According to a report published by Legal NewsLine, the company … Continue reading

Antibiotic Peripheral Neuropathy Lawsuits Move Forward, as Court OK’s Defendant Fact Sheet

Hundreds of antibiotic peripheral neuropathy lawsuits filed against the manufacturers of Cipro, Avelox and Levaquin continue to move forward in the U.S. District Court, District of Minnesota. According to an Order dated July 29th, the Court has approved a Defendant … Continue reading

Another Taxotere Lawsuit Claims Hair Loss Risk Was Concealed

A new Taxotere lawsuit has been filed in San Diego federal court on behalf of a woman who allegedly experienced permanent hair loss following treatment with the chemotherapy medication. Like similar cases currently pending in courts around the U.S, the … Continue reading

Lawsuit Alleges Invokana Makers Put Profits Ahead of Patient Safety

Yet another Invokana lawsuit has been filed on behalf of a patient who allegedly developed ketoacidosis as a result of the Type 2 diabetes medication. Among other things, the complaint claims that the drug’s manufacturers were aware that Invokana could … Continue reading

Plaintiffs Pull Motion Seeking Essure Lawsuit Centralization

Oral arguments regarding the proposed centralization of federally-filed Essure birth control lawsuits have been canceled. Per an Order issued by the U.S. Judicial Panel for Multidistrict Litigation (JPML) on August 12, plaintiffs have requested that their motion seeking consolidation of … Continue reading

Follow Us

RXInjuryHelp.com on Google+  RXInjuryHelp.com on Facebook  RXInjuryHelp.com on LinkedIn  RXInjuryHelp.com on Twitter  RXInjuryHelp.com on YouTube  RXInjuryHelp.com on Pinterest

Skip to content